Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Short term Debt (2022 - 2025)

Historic Short term Debt for Coeptis Therapeutics Holdings (COEP) over the last 3 years, with Q1 2025 value amounting to $635489.0.

  • Coeptis Therapeutics Holdings' Short term Debt changed N/A to $635489.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $635489.0, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Coeptis Therapeutics Holdings' Short term Debt is $635489.0.
  • In the past 5 years, Coeptis Therapeutics Holdings' Short term Debt registered a high of $1.0 million during Q4 2024, and its lowest value of $333335.0 during Q3 2022.
  • For the 3-year period, Coeptis Therapeutics Holdings' Short term Debt averaged around $670102.7, with its median value being $635489.0 (2025).